Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorBaysal, Merve
dc.contributor.authorIlgın, Sinem
dc.contributor.authorAydoğan Kılıç, Gözde
dc.contributor.authorKılıç, Volkan
dc.contributor.authorUçarcan, Şeyda
dc.contributor.authorAtlı Eklioğlu, Özlem
dc.date.accessioned2019-10-19T16:02:48Z
dc.date.available2019-10-19T16:02:48Z
dc.date.issued2017
dc.identifier.issn1932-6203
dc.identifier.urihttps://dx.doi.org/10.1371/journal.pone.0175990
dc.identifier.urihttps://hdl.handle.net/11421/13932
dc.descriptionWOS: 000399875200060en_US
dc.descriptionPubMed ID: 28419133en_US
dc.description.abstractLevetiracetam (LEV) is an antiepileptic drug commonly used in the treatment of epilepsy because of its excellent safety profile in all age groups. It is remarkable that there are no studies evaluating the toxic effects of this drug on the male reproductive system, as it is commonly used in male patients of reproductive age. From this point of view, our aim was to evaluate the possible toxic effects of LEV on the male reproductive system. Therefore, LEV was administered to male rats orally at 50, 150, and 300 mg/kg for 70 consecutive days. At the end of this period, alterations to body and organ weights were calculated, and sperm concentration, motility, and morphology were investigated by a computer-assisted sperm analysis system. Sperm DNA damage was determined by comet assay and histopathological examination of the testes was carried out. Serum testosterone, follicle-stimulating hormone (FSH), and luteinizing hormone (LH) levels were measured by ELISAs to determine the effects of hormonal status, while glutathione, superoxide dismutase, catalase, and malondialdehyde levels in the testes were measured by colorimetric assay kits to determine the role of oxidative status in potential toxicity. According to the results, sperm quality was decreased by LEV treatment in a dose-dependent manner. LEV induced significant DNA damage in the 150 and 300 mg/kg LEV-administered groups. Histopathology of the testes showed that LEV resulted in testicular injury in the 300 mg/kg LEV-administered group. Serum testosterone, FSH, and LH levels were significantly decreased in the 300 mg/kg LEV-administered group. Glutathione, superoxide dismutase, and catalase levels were significantly decreased in all experimental groups while malondialdehyde levels were significantly increased in 150 and 300 mg/kg LEV-administered groups. According to these results, it was determined that LEV administration decreased sperm quality and it was alleged that hormonal alteration and oxidative stress are potential contributors to reproductive toxicity.en_US
dc.description.sponsorshipAnadolu University Scientific Research Projects Commission [1505S412]en_US
dc.description.sponsorshipThis study was supported by the Anadolu University Scientific Research Projects Commission under grant no 1505S412.en_US
dc.language.isoengen_US
dc.publisherPublic Library Scienceen_US
dc.relation.isversionof10.1371/journal.pone.0175990en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleReproductive toxicity after levetiracetam administration in male rats: Evidence for role of hormonal status and oxidative stressen_US
dc.typearticleen_US
dc.relation.journalPlos Oneen_US
dc.contributor.departmentAnadolu Üniversitesi, Eczacılık Fakültesi, Farmasötik Toksikoloji Anabilim Dalıen_US
dc.identifier.volume12en_US
dc.identifier.issue4en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US]
dc.contributor.institutionauthorIlgın, Sinem
dc.contributor.institutionauthorAydoğan Kılıç, Gözde
dc.contributor.institutionauthorKılıç, Volkan
dc.contributor.institutionauthorUçarcan, Şeyda
dc.contributor.institutionauthorAtlı Eklioğlu, Özlem


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster